Detalles de la búsqueda
1.
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence.
Brain Tumor Pathol
; 40(2): 109-123, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36892668
2.
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas.
Brain Tumor Pathol
; 39(2): 79-87, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292862
3.
Immunohistochemistry for O6-methylguanin-DNA methyltransferase in glioblastomas defined by WHO2016: Correlation with promoter methylation status and patients' progression-free survival with the cut-off value determined by ROC analysis.
J Clin Neurosci
; 73: 231-236, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32070670
4.
The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas.
Neurosurgery
; 87(2): 408-417, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31833548
5.
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
Acta Neuropathol Commun
; 8(1): 201, 2020 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33228806
6.
Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis.
Brain Tumor Pathol
; 36(4): 135-143, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31324999
7.
A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma.
Oncotarget
; 9(30): 21569-21579, 2018 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29765561
Resultados
1 -
7
de 7
1
Próxima >
>>